Logo
Banner

Development of Vaccine Against Superbugs

Superbugs are bacteria that are resistant to multiple types of antibiotics, making them difficult to treat and potentially life-threatening. The development of vaccines against superbugs is an important area of research because vaccines can help prevent infections from occurring in the first place and reduce the need for antibiotics.

At Ace Therapeutics, we are committed to providing the highest quality service to our clients. We provide development services of vaccine against superbugs with fast turnaround times, cost-effectiveness, and unparalleled technical expertise. And our team is always available to answer any questions and provide support throughout the entire vaccine development process.

Vaccine Development Services for Various Targets

  • One potential strategy for tackling the issue of superbugs is to develop vaccines that specifically target the outer membrane proteins (OMPs) that are essential for the bacteria's survival. They represent an attractive target for vaccine development. We establish close collaboration with our esteemed clients to identify and pinpoint the OMPs that hold the most potential as effective vaccine targets.
  • Superbug bacteria owe their pathogenicity to bacterial toxins they produce. These toxins perform a critical role in bacterial infections by inflicting harm to the host tissues and evading the host's immune response. We offer vaccine development services that target bacterial toxins of superbugs. We can employ recombinant DNA technology to create vaccines that trigger the immune system's response against the toxins.
  • To combat biofilm-forming superbugs, a biofilm-specific vaccine is needed. Our biofilm-specific vaccine design and development services, as well as our novel vaccine strategies, offer a promising avenue for combating superbugs and improving public health.
  • Antibiotic-resistant genes are the genes that encode for the mechanisms that bacteria use to resist antibiotics. We offer vaccine development services targeting antibiotic-resistant genes of superbugs, including a range of vaccine development services, such as target identification, antigen selection, vaccine design, preclinical testing, and clinical trials.
  • Quorum sensing is a complex communication system that allows bacteria to coordinate their behavior and establish infection in the host. We recognize the urgent need for innovative approaches to combat these superbugs, and our vaccine development services offer customized solutions to target quorum sensing and disrupt the communication networks of these pathogens.

Development Capabilities

We provide scientists with the unique ability to adapt to the future emergence of antibiotic resistant superbugs, aiming to provide effective vaccine development for the global emergence of multi-drug resistant bacteria. Our unique development capabilities include,

  • A multidisciplinary approach involving microbiology, immunology, and vaccine design
  • Infrastructure, and expertise
  • Delivery system development
  • Animal models development
  • Assays development

Thank you for considering Ace Therapeutics as your partner in the fight against superbugs. We look forward to working with you to develop innovative and effective vaccine solutions that make a difference in the lives of patients worldwide.

To learn more about vaccine development for superbugs, please contact us.

All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Get in touch with our team immediately.